Trifluridine and tipiracil demonstrates overall survival benefit for patients with metastatic gastric cancer
Newly released data from the pivotal Phase III trial (TAGS) for trifluridine and tipiracil (TAS-102)…
Browsing: tipiracil
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Potential therapeutic targets to inhibit colorectal cancer progression
- UK Lockdowns: Significant reduction in new cancer diagnoses
- More than half of cancer survivors have underlying medical conditions associated with severe COVID
- Providing inclusive care for LGBTQ2SPIA cancer patients
- Breast cancer-on-a-chip for testing immunotherapy drugs
- Study shows aspirin before a diagnosis may lower colorectal cancer mortality
- Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
- Hypoxia reprograms methylation of ribosomal RNAs
